RE:YOUTH (YONSEI BH Arterial Stemcell Clinic)
BookimedはC型肝炎治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。C型肝炎治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。C型肝炎治療の旅路でお一人になることはありません。
Hepatitis C treatment in Korea achieves a success rate between 95% and 100% using direct-acting antiviral agents. These modern oral medications provide high cure rates across different genotypes. KOIHA-accredited clinics ensure international safety standards while delivering advanced therapies for liver health.
Bookimed Expert Insight: Korea is uniquely positioned for patients with advanced liver complications from Hepatitis C. Clinics like RE:YOUTH in Cheonan offer breakthrough arterial stem cell therapy. This method delivers 100% of cells directly to the liver. This specifically helps address cirrhosis where traditional drugs alone may not suffice. It is a rare option not found in many other top-tier medical hubs.
Hepatitis C treatment in South Korea typically lasts 8 to 12 weeks using modern antivirals. Standard oral regimens achieve cure rates exceeding 95% within this timeframe. Patients with advanced liver damage or specific viral genotypes may require extended protocols for up to 24 weeks.
Bookimed Expert Insight: South Korea offers a unique specialized approach for liver health beyond standard antivirals. Clinics like RE:YOUTH facilitate arterial stem cell therapy specifically for liver conditions. This focused delivery method aims to support organ recovery alongside traditional infection management. Dr. Jin Yong Kim at the center brings expertise from Johns Hopkins and Harvard. This level of specialization is ideal for patients seeking comprehensive liver care.
South Korea National Health Insurance covers Hepatitis C treatment. The system includes direct-acting antiviral drugs with success rates over 90%. Coverage typically includes diagnostic tests and prescription medications. Patients must use specific infection codes to qualify for reimbursement at accredited medical facilities.
Bookimed Expert Insight: Foreign patients should verify their visa eligibility for National Health Insurance enrollment immediately. Clinics like RE:YOUTH in Cheonan hold KOIHA accreditation, ensuring they meet international safety standards. Working with experienced specialists like Dr. Jin Yong Kim, who has Harvard and Johns Hopkins training, helps ensure accurate diagnostic coding for insurance claims.
Patient Consensus: Patients emphasize obtaining hospital pre-approval for antiviral drugs to keep out-of-pocket costs low. Many recommend seeking care at major centers for better access to English-speaking specialists.
Hepatitis C treatment in the Republic of Korea achieves a success rate exceeding 95%. This success comes from using direct-acting antiviral agents. Clinical data shows a 96.1% cure rate for therapies started between 2015 and 2019. Most patients clear the virus after 8 to 12 weeks of oral medication.
Bookimed Expert Insight: South Korea provides high-level gastroenterology expertise that bridges viral treatment and regenerative care. While major hospitals focus on 96.1% cure rates, clinics like RE:YOUTH in Cheonan offer specialised stem cell therapy. This helps patients who have related liver cirrhosis. This dual-track availability makes Korea a specific destination for complex cases.
Hepatitis C treatments in South Korea are safe and highly effective. Direct-acting antiviral therapies report cure rates exceeding 95%. These treatments follow guidelines from the Korean Association for the Study of the Liver. Facilities like RE:YOUTH hold KOIHA accreditation for international safety standards.
Bookimed Expert Insight: Safety in Korea is linked to the high level of academic expertise in gastroenterology. Specialists like Dr Jin Yong Kim have held roles at Harvard and Johns Hopkins. These backgrounds mean local protocols reflect the latest global safety and pharmaceutical standards.
Patient Consensus: Patients note that modern treatments in Korea are easier to complete than older therapies. They suggest confirming drug names and checking that the plan includes viral load testing.
Hepatitis C treatment in South Korea follows international standards using Direct-Acting Antiviral (DAA) medications. These oral therapies achieve cure rates above 90% within 8 to 12 weeks. Specialised centres in Seoul and Cheonan provide care based on genotype and liver health.
Bookimed Expert Insight: Most Korean hospitals follow standard DAA protocols. However, patients with advanced cirrhosis have access to rare regenerative options. RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) serves only 2 patients daily for intensive, customised care. This level of focus is rare in Korea’s high-volume medical landscape. It provides a safer environment for complex cases requiring stem cell infusion alongside standard antivirals.
Screening for liver cirrhosis is essential before starting Hepatitis C treatment in South Korea. Doctors must assess liver scarring to determine the correct medication dose and treatment length. This step also identifies patients who need ongoing liver cancer monitoring after the virus is cleared.
Bookimed Expert Insight: South Korea is a leading destination for complex gastrointestinal care. It currently ranks eighth globally in our network. This high volume is supported by specialists like Dr Eun Seong Seon. He focuses specifically on preventive health screenings. Patients can find initial gastroenterologist consultations in leading Korean clinics for approximately A$60 to A$100.
Patient Consensus: Patients note that staging through FibroScan or blood tests is standard before starting therapy. They recommend bringing existing ultrasound or biopsy results from home. This helps clinicians coordinate the treatment plan quickly.
Medical tourists can access Hepatitis C testing at major JCI-accredited tertiary hospitals and specialised screening centres in South Korea. Facilities like Severance Hospital and Asan Medical Center provide diagnostic antibody and RNA testing. These services are available through dedicated international healthcare centres. Gastroenterology consultations typically cost between A$60 and A$100.
Bookimed Expert Insight: South Korea's screening infrastructure is exceptionally robust. Specialists like Dr Eun Seong Seon have extensive experience in national health insurance frameworks. This ensures standard diagnostic protocols are highly regulated. Patients seeking Hepatitis C testing should look for doctors with Master of Public Health degrees. These specialists often lead the most efficient screening programs in Seoul.
Patient Consensus: Patients recommend contacting international centres directly to confirm same-day RNA testing and English support. Those visiting Korea suggest checking referral requirements for liver clinics before travel to avoid delays.